Boston Scientific Corporation acquires pioneer firm in coronary artery disease treatment, Bridgepoint Medical, for an undisclosed sum in a bid to beef up their cardiology portfolio.
Boston Scientific Corporation, a publicly traded company which develops and manufactures medical equipment has signed agreements to acquire startup Bridgepoint Medical for an undisclosed sum.
Bridgepoint Medical, founded in 2007 in Minneapolis ,develops technology and techniques used to treat coronary artery disease. The firm currently produces a catheter-based system to treat chronic total occlusions (CTOs) that would normally require surgery. Boston Scientific hopes its acquisition will expand and strengthen its cardiology portfolio.
Earlier this year Bridgepoint Medical licensed its peripheral…
